Understanding Intellectual Property

Introduction and Representative Profile

  • Speaker: Dr. Grace Chan, PhD in Chemistry, Patent & Trade Mark Attorney.

  • Role: Senior Intellectual Property (IP) Manager at Research, Innovation & Commercialisation (RIC), University of Melbourne.

  • Division: Innovation & Enterprise Commercialisation under DVC Research.

  • Functional Areas:

    • Grants & Genesis Pre-Seed Fund.

    • Research Ethics & Integrity.

    • Knowledge & Technology Transfer: Assisting the academic community in safeguarding and translating IP generated through research for social, environmental, and economic impact.

  • Date of Presentation: 20 May 2026.

Understanding Intellectual Property (IP)

  • Core Definition: IP is defined as the "product of the mind."

  • IP at the Heart of Research: It encompasses diverse outputs including:

    • Preliminary results and research findings.

    • New processes, methodologies, and compositions.

    • Software, algorithms, and novel particles.

    • Teaching and course materials.

    • Devices, sculptures, and artistic works.

    • Literary works, sound recordings, and films.

  • Utility of IP: IP acts as a bridge for:

    • Academic Advancement: Research grants, publications, theses, and academic promotion.

    • External Engagement: Industry collaboration, government advice, and community engagement.

    • Commercialisation: Licensing to society, establishing Start-up enterprises, Social Enterprises, and Non-profits to deliver products and services.

Comprehensive Taxonomy of Intellectual Property Rights

  • 1. Confidential Information:

    • Non-Registered: Trade secrets, know-how, expertise, and scientific/technical knowledge.

    • Specific Examples: Algorithms, recipes, formulas, experimental data, pre-patent research, customer databases, and strategic plans.

    • Protection Mechanism: Confidentiality Agreements (CDAs) or Non-Disclosure Agreements (NDAs).

    • Duration: Indefinite, provided the secret is not disclosed. There is no protection against independent discovery.

  • 2. Copyright:

    • Protects: The original creative expression of an idea in material (physical) form. It does not protect the idea itself.

    • Categories: Literary works (books, computer programs, publications), artistic works (paintings, sculptures), musical works (scores), dramatic works (scripts, choreography), and multi-media (films, sound broadcasts).

    • Status: Automatic right upon creation; registration is not required in Australia.

    • Duration: Lasts for the life of the author plus 7070 years.

    • Note: "Freely available" does not mean "Free to Use."

  • 3. Registered Designs:

    • Protects: The overall appearance, relating to visual features such as shape, configuration, pattern, or ornamentation.

    • Requirements: Must be novel and distinctive.

    • Duration: Registration lasts up to 1010 years.

    • Limitation: Protection can be circumvented if a competitor changes the design enough to result in a different overall visual impression.

  • 4. Trade Marks:

    • Purpose: Signs used to distinguish a trader’s goods and services.

    • Forms: Words (e.g., IPHONE), logos, phrases, shapes, colours, scents, movements, or sounds.

    • Status: Can be registered (indicated by the ®\circledR symbol) or unregistered.

    • Duration: Indefinite, provided they are renewed every 1010 years.

    • Restriction: Purely descriptive terms (e.g., "MELBOURNE CARS") are generally not registrable to allow public use.

  • 5. Patents:

    • Definition: A granted right to exclude others from making, using, or selling an invention.

    • Social Contract: A legal monopoly granted by the government in exchange for the public disclosure of the invention's details.

    • Duration: Maximum of 2020 years.

  • 6. Other Forms:

    • Plant Breeders Rights: For new varieties of fruit, plants, flowers, and vines.

    • Domain Names: Examples include .com, .edu, .net, .biz, and country codes like .au or .uk.

    • Business Names: Trading names for entities.

A Deeper Dive into Patents

  • What Can Be Patented?

    • Compositions of matter (compounds, biologicals).

    • Methods of manufacture.

    • Methods or processes of use/application (a series of steps to achieve a result).

    • Machines or devices (inter-operable parts or articles of manufacture).

  • What Cannot Be Patented?

    • Discoveries found in nature (e.g., finding beneficial bacteria in soil).

    • Abstract ideas, schemes, and plans.

    • Pure algorithms and mathematical formulae.

  • Example of Patentable Progression:

    • Finding bacteria in soil: Discovery (Not Patentable).

    • Process for isolating bacteria while maintaining activity: Method (Patentable).

    • Method of applying bacteria in specific amounts to promote wheat yield: Process of Use (Patentable).

    • Fertilizer composition containing the bacteria in stable form: Composition (Patentable).

Legal Requirements for Patentability

  • 1. Novelty: The invention must not be known or exist anywhere in the world. It is assessed against "prior art," which includes:

    • Documents available publicly worldwide.

    • Public acts of use.

    • Public disclosures like conference talks or social media posts.

    • Note: A single piece of prior art describing the invention is enough to destroy novelty.

  • 2. Inventive Step: The invention must not be an obvious development to a person skilled in the art based on existing knowledge.

  • 3. Usefulness (Utility): The invention must have a practical application and solve a specific problem.

Strategic IP Management and Ownership

  • Timing and Public Disclosure:

    • In patents, timing is critical. Filing a provisional patent application must happen before any public disclosure.

    • Public disclosures include: Published papers, social media uploads, conference presentations/abstracts, and PhD thesis submissions to libraries.

    • Internal discussions within the same organization are usually not public disclosures, but external discussions are.

    • Patent Publication Lag: There is an 1818-month time lag between the initial filing of a patent and its public publication in databases (e.g., WIPO Patentscope, Espacenet, Google Patents).

  • IP Ownership Factors:

    • Identity of the creators/inventors.

    • Employment obligations (Staff vs. Third-party).

    • Funding agreements (e.g., ARC Linkage).

  • University of Melbourne (UoM) Policy:

    • Governed by the University of Melbourne Statute and IP Policy (MPF13201320).

    • Staff: UoM owns IP created in the course of employment (except copyright in scholarly works).

    • Students: For graduate research students (post-11 October 20232023), the University may require IP assignment as a condition for participating in specific research activities.

    • UoM owns all IP that constitutes teaching material.

Freedom to Operate (FTO) and Infringement

  • FTO Definition: The ability to carry out work without infringing the legal rights (like patent claims) of a third party in a specific country.

  • Patent Claims: These act like a "fence" or boundary. If your activity falls inside that boundary, you are an infringer.

  • Managing Risks:

    • Conduct specialist FTO searches.

    • Design around existing patents to avoid boundaries.

    • Seek a license from the IP owner.

Case Study: Clarity Pharmaceuticals & SAR Technology

  • Technical Breakdown: SAR Technology platform involves a "Cage" (chelator) that securely holds radioisotopes, connected via a "Linker" to a "Targeting molecule" that binds to specific receptors (proteins) on cancer cells.

  • Isotopes Used:

    • 64Cu^{64}Cu: Used for Positron Emission Tomography (PET) imaging.

    • 67Cu^{67}Cu: Used for therapy.

  • Development Pathway:

    • Research led by Professor Paul Donnelly (UoM School of Chemistry).

    • IP disclosed in 20082008; provisional filed in December 20082008.

    • Clarity Pharmaceuticals licensed the technology in 20102010.

    • Currently protected by 88 patent families.

    • Clarity acquired full ownership of patents in early 20212021.

    • Impact: Development of cancer theranostics for prostate cancer, breast cancer, and paediatric neuroblastoma.